100% committed to ending dementia. For good.

All in to end Alzheimer disease.

CLEAR is the only Canadian foundation that directs 100% of funds raised to promising scientific research into the cause, prevention, and treatment of Alzheimer disease and other dementias.

Because it’s clear: the only path to a cure is more research.



people living with dementia in Canada

Even more alarmingly, by 2031 this number is expected to exceed 1 million.


research projects funded by CLEAR

Each of these projects has contributed to our collective understanding of dementia.


leading cause of death in Canada

Every year, over 6,000 Canadians die from the disease. That’s 16 loved ones lost each day.


of funding provided to researchers

We will keep funding promising research until we have the cure the world has been waiting for.

Past & Present Research

Validation of Connexins and Pannexins as a target for Alzheimer’s Disease

ABSTRACT Alzheimer’s Disease (AD) is the most common cause of dementia, accounting for over two thirds of cases. There are currently no successful treatments, making the discovery of effective therapeutic interventions critical. The brain contains billions of neurons, and substantially more non-neuronal cells called glia; the major ones relevant to this proposal are astrocytes. While…

See This Project

Voices in Motion

Q: What did we learn? Research findings demonstrate choral singing to be a joyful social experience that reinforces participants’ sense of identity, competence, and accomplishment. Social singing is a superstimulus, drawing upon emotional and procedural brain systems unaffected by dementia, which permits those with the disease to participate to the same degree as any other…

See This Project

Non-invasive imaging of Alzheimer Disease biomarkers in the brain and eye

ABSTRACT Age related neurodegenerative diseases such as Alzheimer’s Disease (AD) affect ~500,000 Canadians, and the economic burden of dementia was $15 billion in 2008. Early diagnosis and novel therapies are needed to improve the quality of life of affected individuals, and to reduce costs to the Canadian health care system. However, screening for irreversible hallmarks…

See This Project

Locally produced brain insulin in memory and Alzheimer’s disease: A multi-disciplinary approach to a key question

ABSTRACT One percent of Alzheimer’s disease is the early-onset type that runs in families. Extensive studies of these ultra-rare forms of Alzheimer’s disease have revealed the genes that cause them. On the other hand, the most common forms of Alzheimer’s disease are surprisingly understudied and poorly understood at the level required for therapeutic intervention. However,…

See This Project

Together, we can find a cure for Alzheimer disease.

Sign up for Untangling Alzheimers, our newsletter: